¹  .Denning D W : State-of-the-art clinical article: Invasive Aspergillosis. Clinical Infectious Diseases, 1998; 26: 781-805.

²  . Fresenius J B G W: Beitrag zur Mykologie 3

³  .Latgé JP: Aspergillus fumigatus. Clinical Microbiology Reviews, 1999; 12 (2): 310-350.

⁴  .Chazalet V, Debeaupuis JP, Sarfati J et al.: Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings. Journal of Clinical Microbiology, 1998; 36 (6): 1494-1500.

⁵  .Walsh TJ, Dixon DM: Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. European Journal of Epidemiology, 1989; 5 (2): 131-142.

⁶  .Weems J J, Davis B J, Tablan O C et al.: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infection Control and Hospital Epidemiology, 1987; 8 (2): 71-75.

⁷  .Leenders A C A P, van Belkum A, Behrendt M et al.: Density and Molecular Epidemiology of Aspergillus in Air and Relationship to Outbreaks of Aspergillus Infection. Journal of Clinical Microbiology, 1999; 37 (6): 1752-1757.

⁸  .Curtis L, Cali S, Conroy L et al.: Aspergillus surveillance project at a large tertiary-care hospital. Journal of Hospital Infection, 2005; 59 : 188-196.

⁹  .Patterson T F, Kirkpatrick W R, White M et al.: Invasive Aspergillosis, Disease Spectrum, Treatment Practices and Outcomes. MEDICINE, 2000; 79 (4): 250-260.

¹⁰  .Dixon, D M, McNeil M M, Cohen M L et al.: Fungal infections: a growing threat. Public Health Reports, 1996; 3 (111): 226-235.

¹¹  .Wanke B, Santos Lazéra M dos, Nucci M: Fungal infections in the immunocompromised Host. Mem Inst Oswaldo Cruz

¹²  .Stevens D A, Kan V L, Judson M A et al.: Practice Guidelines for Diseases Caused by Aspergillus. Clinical Infectious Diseases, Society of America, 2000; 30: 696-709.

¹³  .Van`t Hek L G, Verweij P E, Weemaes C M et al.: Successful Treatment with Voriconazol of Invasive Aspergillosis in Chronic Granulomatous Disease. American Journal of Respiratory and Critical Care Medicine, 1998; 157 : 1694-1696.

¹⁴  .Mouy R, Fischer A, Vilmer E et al.: Incidence, severity, and prevention of infections in chronic granulomatous disease. Journal of Pediatrics, 1989; 114: 555-560.

¹⁵  .Kirsten D, Rieger U, Amthor M, Magnussen H: Invasive aspergillosis in cavitary lung sarcoidosis. Pneumologie, 1992; 46 (6): 239-242.

¹⁶  .Kemper C A, Hostetler J S, Follansbee S E et al.: Ulcerative and plaquelike tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clincal Infectious Diseases, 1993; 17 : 344-352.

¹⁷  .Solé A, Morant P, Salavert M et al.: Aspergillus infections in lung transplant recipients: risk factors and outcome. Clinical Microbiology & Infection, 2005; 11 (5): 359-365.

¹⁸  .Kramer M R, Denning D W, Marshall S E et al.: Ulcerative tracheobronchitis following lung transplantation: a new form of invasive aspergillosis. American Review of Respiratory Disease, 1991 ; 144 : 522-526.

¹⁹  .Drakos P E, Nagler A, Or R et al.: Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplantation, 1993; 12 (3): 203-208.

²⁰  .Polzehl D, weschta m, Podbielski A et al.: Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis. Journal of Medical Micribiology, 2005; 54 : 31-37.

²¹  .Denning D W: Therapeutic outcome in invasive aspergillosis. Clinical Infectious Diseases, 1996; 23: 608-615.

²²  .Groll A H, Shah P M, Mentzel et al.: Trends in the Postmortem Epidemiology of Invasive Fungal Infections at a university hospital. Journal of Infection,1996; 33 (1): 23-32.

²³  .Wald A, Leisenring W, van Burik JA, Bowden RA: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. Journal of Infectious Diseases, 1997, 175 (6): 1459-1466.

²⁴  .Hunter A, Haynes A, Russell N: Bone marrow transplantation: current situation, complications and prevention. Journal of Antimicrobial Chemotherapy, 1995; 36 (Suppl. B): 119-133.

²⁵  .Fishman, J A, Rubin R H: Infection in Organ-Transplant Recipients. The New England Journal of Medicine 1998; 338 : 1741-1751.

²⁶  .Bow E J, Loewen R, Cheang M S, Schacter B: Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clinical Infectious Diseases, 1995; 21 (2): 361-369.

²⁷  .Einsele H, Quabeck K, Muller K D et al.: Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet, 1998; 352 (9138): 1443.

²⁸  .Von Eiff M, Roos N, Schulten R et al.: Pulmonary aspergillosis: early diagnosis improves survival. Respiration, 1995; 62 (6): 341-347.

²⁹  .Aisner J, Wiernik P H, Schimpff S C: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Annals of Internal Medicine, 1977; 86 (6): 539-543.

³⁰  .Kontoyiannis D P, Bodey G P: Invasive Aspergillosis in 2002: an update. European Journal of Clinical Microbiology & Infectious Diseases, 2002; 21 (3): 161-172.

³¹  .Caillot D, Casanovas O, Bernard A et al.: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. Journal of Clinical Oncology, 1997; 15: 139-147.

³²  .Maschmeyer G, Link H, Hiddemann W et al.: Pulmonary Infiltrations in Febrile Patients with Neutropenia. Cancer, 1994; 73 (9): 2296-2304.

³³  .Diederich S, Scadeng M, Dennis C et al.: Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings. Eur. Radiol, 1998; 8 (2): 306-312.

³⁴  .Heussel C P, Ullmann A J, Kauczor HU: Pilzpneumonie. Radiologe, 2000; 40: 518-529.

³⁵  .Ascioglu S, Rex J H, de Pauw B et al.: Definig Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus. Clinical Infectious Diseases, 2002; 34: 7-14.

³⁶  .Seyfahrt HJ, Nenoff P, Winkler J et al.: Invasive Pulmonale Aspergillose – CT-Befunde im Kontext des klinischen Verlaufes. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2002, 174: 1115-1120.

³⁷  .Loeffler J, Kloepfer K, Hebart H et al.: Polymerase Chain Reaction Detection of Aspergillus DNA in Experimental Models of Invasive Aspergillosis. The Journal of Infectious Diseases, 2002; 185: 1203-1206.

³⁸  .Rimek D, Garg A P, Kappe R, Sonntag H G: Pilz-Nukleinsäure-Nachweis bei invasiven Aspergillosen. Mycoses 1998; 41 (Suppl.2): 65-68.

³⁹  . Einsele H, Bertz H, Beyer J et al.: Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation. Deutsche Medizinische Wochenschrift, 2001; 1278-1284.

⁴⁰  . Reimer L G, Wilson M L, Weinstein M P: Update on Detection of Bacteremia and Fungemia. Clinical Microbiology Reviews, 1997; 10 (3): 444-465.

⁴¹  .Maertens J, Verhaegen J, Demuynck H et al.: Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis. Journal of Clinical Microbiology, 1999; 37 (10): 3223-3228.

⁴²  .Sanguinetti M, Posteraro B, Pagano L et al.: Comparison of Real-Time PCR, Conventional PCR, and Galactomannan Antigen Detection by Enzyme-Linked Immunosorbent Assay Using Bronchoalveolar Lavage Fluid Samples from Hematology Patients for Diagnosis of Invasive Pulmonary Aspergillosis. Journal of Clinical Microbiology, 2003; 41 (8): 3922-3925.

⁴³  .Maertens J, Verhaegen J, Lagrou K et al.: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: aprospective validation. Blood, 2001; 97: 1604-1610.

⁴⁴  .Herbrecht R, Letscher-Bru V, Oprea C et al.: Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis. Journal of Clinical Oncology, 2002; 20 (7): 1898-1906.

⁴⁵  .Musher B, Fredricks D, Leisenring W et al.: Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 2004; 42 (12): 5517-5522.

⁴⁶  .Becker M J, de Marie S, Willemse D et al.: Quantitative Galactomannan Detection Is Superior to PCR in Diagnosing and Monitoring Invasive Pulmonary Aspergillosis in an Experimental Rat Model. Journal of Clinical Microbiology, 2000; 38 (4): 1434-1438.

⁴⁷  .Van Burik JA, Myerson D, Schreckhise R W et al.: Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens. Journal of Clinical Microbiology, 1998; 36 (5): 1169-1175.

⁴⁸  .Hopfer R L, Walden P, Setterquist S, Highsmith W E: Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. Journal of Medical and Veterinary Mycology, 1993; 31: 65-75.

⁴⁹  .Makimura K, Murayama S Y, Yamaguchi H: Detection of a wide range of medically important fungi by the polymerase chain reaction. Journal of Medical Microbioloy, 1994; 40: 358-364.

⁵⁰  .Sandhu G S, Kline B C, Stockmann L, Roberts G D: Molecular Probes for Diagnosis of Fungal Infections. Journal of Clinical Microbiology, 1995; 33 (11): 2913-2919.

⁵¹  .Melchers W J G, Verweij P E, van den Hurk P et al.: General Primer-Mediated PCR for Detection of Aspergillus Species. Journal of Clinical Microbiology, 1994; 32 (7): 1710-1717.

⁵²  .Reddy L V, Kumar A, Kurup V P: Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Molecular and Cellular Probes, 1993; 7: 121-126.

⁵³  . Skladny H, Buchheidt D, Baust C et al.: Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR. Journal of Clinical Microbiology, 1999; 37 (12): 3865-3871.

⁵⁴  .Lee L G, Connell C R, Bloch W: Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Research, 1993; 21 (16): 3761-3766.

⁵⁵  .Loeffler J, Hebart H, Schumacher U et al.: Comparison of Different Methods for Extraction of DNA of Fungal Pathogens from Cultures and Blood. Journal of Clinical Microbiology, 1997; 35 (12): 3311-3312.

⁵⁶  .Müller FM C, Werner K E, Kasai M et al.: Rapid Extraction of Genomic DNA from Medically Important Yeasts and Filamentous Fungi by High-Speed Cell Disruption. Journal of Clinical Microbiology, 1998; 36 (6): 1625-1629.

⁵⁷  . Förster V T: Zwischenmolekulare Energiewanderung und Fluoreszenz. Anals of Physics, 1948; 2: 55-75.

⁵⁸  .Livak K J, Flood S J A, Marmaro J et al.: Oligonucleotides with Fluorescent Dyes at Opposite Ends Provide a Quenched Probe System Useful for Detecting PCR Product and Nucleic Acid Hybridization. PCR Methods and Applications, 1995; 4: 357-367.

⁵⁹  .Schild T A: Einführung in die Realtime-TaqMan-PCR-Technologie; 1996: 1-39.

⁶⁰  .Subirà M, Martino R, Rovira M et al.: Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematology, 2003; 82: 80-82.

⁶¹  .Haynes K, Westerneng T, Fell J, Moens W: Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. Journal of Medical Veterinary Mycology, 1996; 33: 319-325.

⁶²  .Einsele H, Hebart H, Roller G et al.: Detection and Identification of Fungal Pathogens in Blood by Using Molecular Probes. Journal of Clinical Microbiology, 1997; 35 (6): 1353-1360.

⁶³  .Williamson E C M, Leeming J P, Palmer H M et al.: Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chaim reaction. British Journal of Haematology, 2000; 108: 132-139.

⁶⁴  .Loeffler J, Hebart H, Bialek R et al.: Contaminations Occurring in Fungal PCR Assays. Journal of Clinical Microbiology, 1999; 37 (4): 1200-1202.

⁶⁵  .Hayette MP, Vaira D, Susin F et al.: Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 2001; 38 (6): 2338-2340.

⁶⁶  .Tang C M, Holden D, Aufauvre-Brown A, Cohen J: The Detection of Aspergillus spp. By the Polymerase Chain Reaction and Its Evaluation in Bonchoalveolar Lavage Fluid. Amreican Review of Respiratory Disease, 1993; 148: 1313-1317.

⁶⁷  .Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M: PCR Detection of DNA Specific for Aspergillus Species i Serum of Patients with Invasive Aspergillosis. Journal of Clinical Microbiology, 1996; 34 (10): 2464-2468.

⁶⁸  .Loeffler J, Henke N, Hebart H et al.: Quantification of Fungal DNA by Using Fluorescence Resonance Energy Transfer and the Light Cycler System. Journal of Clinical Microbiology, 2000; 38 (2): 586-590.

⁶⁹  .Loeffler J, Schmidt K, Hebart H et al.: Automated Extraction of Genomic DANN from Medically Important Yeast Spezies and Filamentous Fungi by Using the MagNA Pure LC System. Journal of Clinical Microbiology, 2002; 40 (6): 2240-2243.

⁷⁰  .Bowman J C, Abruzzo G K, Anderson J W et al.: Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate. Anitmicrobial Agents and Chemotherapy, 2001; 45 (12): 3474-3481.

⁷¹  .Bu R, Sathiapalan R K, Ibrahim M M et al.: Monochrome LightCycler PCR assay for detection and quantification of five common species of Candida and Aspergillus. Journal of Medical Microbiology, 2005; 54: 243-248.

⁷²  .Challier S, Boyer S, Abachin E, Berche P: Development of a Serum-Based TaqMan Real-Time PCR Assay for Diagnosis of Invasive Aspergillosis. Journal of Clinical Microbiology, 2004; 42 (2): 844-846.

⁷³  .Costa C, Vidaud D, Olivi M et al.: Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. Journal of Microbiological Methods, 2001; 44: 263-269.

⁷⁴  .Costa C, Costa JM, Desterke C et al.: Real-Time PCR Coupled with Automated DNA Extraktion and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of invasive Aspergillosis. Journal of Clinical Microbiology, 2002; 40 (6): 2224-2227.

⁷⁵  .Kawazu M, Kanda Y, Nannya Y et al.: Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-ß-D-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders. Journal of Clinical Microbiology, 2004; 42 (6): 2733-2741.

⁷⁶  .Rantakokko-Jalava K, Laaksonen S, Issakainen J et al.: Semiquantitative Detection by Real-Time PCR of Aspergillus fumigatus in Bronchoalveolar Lavage Fluids and Tissue Biopsy Specimens from Patients with Invasive Aspergillosis. Journal of Clinical Microbiology, 2003; 41 (9): 4304-4311.

⁷⁷  .Pryce T M, Kay I D, Palldino S, Heath C H: Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagnostic Microbiology and Infectious Disease, 2003; 47: 487-496.

⁷⁸  .Brandt M E, Padhye A A, Mayer L W et al.: Utility of Random Amplified Polymorphic DNA PCR and TaqMan Automated Detection in Molecular Identification of Aspergillus fumigatus. Journal of Clinical Microbiology, 1998; 36 (7): 2057-2062.

⁷⁹  .Spiess B, Buchheidt D, Baust C et al.: Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients. Journal of Clinical Microbiology, 2003; 41 (5): 1811-1818.

⁸⁰  .Spreadbury C, Holden D, Aufauvre-Brown A et al.: Detection of Aspergillus fumigatus by Polymerase Chain Reaction. Journal of Clinical Microbiology, 1993; 31 (3): 615-621.

⁸¹  .Buchheidt D, Hummel M, Schleiermacher D et al.: Current Molecular Diagnostic Approaches to Systemic Infections with Aspergillus Species in Patients with Hematological Malignancies. Leukemia & Lymphoma, 2004; 45 (3): 463-468.

⁸²  .Jones M E, Fox A J, Barnes A J et al.: PCR-Elisa for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. Journal of Clinical Pathology, 1998; 51: 652-656.

⁸³  .Buchheidt D, Baust C, Skladny H et al.: Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples from Immunocompromised Patients by Means of 2-Step Polymerase Chain Reaction: Clinical Results. Clinical Infectious Diseases, 2001; 33: 428-435.

⁸⁴  .Segal B H, DeCarlo E S, Kwon-Chung K J et al.: Aspergillus nidulans infection in chronic granulomatous disease. Medicine

⁸⁵  .Verweij P E, Weemaes C M, Curfs J H A J et al.: Failure To Detect Circulating Aspergillus Markers in a Patient with Chronic Granulomatous Disease and Invasive Aspergillosis. Journal of Clinical Microbiology, 2000; 38 (10): 3900-3901.

⁸⁶  .Bretagne S, Costa JM, Bart-Delabesse E et al.: Comparison of Serum Galactomannan Antigen Detection and Competetive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis. Clinical Infectious Diseases, 1998; 26: 1407-1412.

⁸⁷  .Buchheidt D, Hummel M, Schleiermacher D et al.: Prospective clinical evaluation of a LightCyclerTM-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. British Journal of Haematology; 125: 196-202.

⁸⁸  .Hashimoto A, Yamakami Y, Kamberi P et al.: Comparison of PCR, (1→3)-ß-D-Glucan and Galactomannan Assays in Sera of Rats With Experimental Invasive Aspergillosis. Journal of Clinical Laboratory Analysis, 1998; 12: 257-262.

⁸⁹  .Kawamura S, Maesaki S, Noda T et al.: Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. Journal of Clinical Microbiology, 1999; 37: 218-220.

⁹⁰  .Verweij P E, Latgé JP, Rijs A J M M et al.: Comparison of Antigen Detection and PCR Assay Using Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis in Patients Receiving Treatment for Hematological Malignancies. Journal of Clinical Microbiology, 1995; 33 (12): 3150-3153.